Cargando…
PU.1 is a major transcriptional activator of the tumour suppressor gene LIMD1
LIMD1 is a tumour suppressor gene (TSG) down regulated in ∼80% of lung cancers with loss also demonstrated in breast and head and neck squamous cell carcinomas. LIMD1 is also a candidate TSG in childhood acute lymphoblastic leukaemia. Mechanistically, LIMD1 interacts with pRB, repressing E2F-driven...
Autores principales: | Foxler, Daniel E., James, Victoria, Shelton, Samuel J., Vallim, Thomas Q. de A., Shaw, Peter E., Sharp, Tyson V. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science B.V
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3078326/ https://www.ncbi.nlm.nih.gov/pubmed/21402070 http://dx.doi.org/10.1016/j.febslet.2011.03.013 |
Ejemplares similares
-
LIMD1 is induced by and required for LMP1 signaling, and protects EBV-transformed cells from DNA damage-induced cell death
por: Wang, Ling, et al.
Publicado: (2017) -
A HIF–LIMD1 negative feedback mechanism mitigates the pro‐tumorigenic effects of hypoxia
por: Foxler, Daniel E, et al.
Publicado: (2018) -
Targeted therapy for LIMD1-deficient non-small cell lung cancer subtypes
por: Davidson, Kathryn, et al.
Publicado: (2021) -
LIMD1‐AS1 suppressed non‐small cell lung cancer progression through stabilizing LIMD1 mRNA via hnRNP U
por: Pan, Jianyuan, et al.
Publicado: (2020) -
Algorithm-Based Meta-Analysis Reveals the Mechanistic Interaction of the Tumor Suppressor LIMD1 With Non-Small-Cell Lung Carcinoma
por: Wang, Ling, et al.
Publicado: (2021)